Healthcare coding has fundamentally transformed from volume-driven revenue capture to compliance-first, defensible documentation standards.
Welcome - Welcome to our sixth issue of 2026 of The Health Record -- our healthcare law insights e-newsletter. Errors ...
An Ormond Beach mental health counselor charged with defrauding the U.S. government of over $262,000, was netted in the 2026 ...
I’ve talked to so many educators, and I just don’t feel like this is making their lives easier,” said board member Liz ...
CMS said June 12 it seeks to shift the Medicare Drug Price Negotiation Program from guidance-based administration to codified regulation. Here is what hospital and health system leaders need to know.
"We continue to make progress against our top priorities of maintaining strong margins, reducing our cost structure and moving the business towards sustainable profitability," said CEO, Secretary & ...
Neil Batlivala has spent seven years building a healthcare company that most of the tech industry has never heard of and that serves a patient population most of Silicon Valley ignores. But last month ...
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) ...
A financially sustainable solution for how to cover GLP-1 drugs for obesity remains elusive. The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan.
The Trump administration's promised Medicare pilot program for GLP-1 weight-lossdrugs was positioned to help cover the costs of these medications, helpingseniors avoidwasting money in retirement while ...
The Trump administration unveiled a new program to speed up Medicare coverage for breakthrough devices, touting that the new pathway cuts red tape for medical device companies to gain reimbursement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results